Skip to content

Morphological assessment of distal aortic remodeling after acute type A aortic dissection surgery: a single-center ambispective cohort study

Morphological assessment of distal aortic remodeling after acute type A aortic dissection surgery: a single-center ambispective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061337
Enrollment
Unknown
Registered
2022-06-21
Start date
2022-06-07
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic dissection

Interventions

ATAAD :surgery

Sponsors

The Second Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who signed the informed consent procedure before surgery and did not withdraw from the agreement before discharge after surgery; 2. Aged >= 18 years, with normal cognitive and communication skills; 3. Based on clinical symptoms, signs and auxiliary examinations such as transthoracic and (or) The results of transesophageal echocardiography, enhanced CT aorta (Aorta Computed Tomography Angiography, Aorta CTA) or surgical exploration results, definite diagnosis of Stanford type A aortic dissection, acute onset of new Stanford type A aorta Dissection or acute-onset Stanford type A aortic dissection on the basis of chronic aortic dissection were included in the study cohort. 4. Dissection remains at the distal end after primary surgery.

Exclusion criteria

Exclusion criteria: 1. Patients who died during hospitalization; 2. Patients whose aortic dissection has been fully treated and no residual double-lumen pathological structure; 3. Stanford type A aortic dissection with more than 90 days from the onset time to the visit 3. If the patient has mental disorders . Recruitment is not recommended when the data collection cannot be completed and the entrusted agent cannot normally perform the follow-up obligations; 4. Other situations judged by the investigator to be unsuitable for inclusion in this clinical cohort study.

Design outcomes

Primary

MeasureTime frame
death;Aortic reintevention;Cerebrovascular accident;

Secondary

MeasureTime frame
Paraplegia;Aortic dilation rate;Aortic false lumen thrombosis;

Countries

China

Contacts

Public ContactLi Qingguo

The Second Affiliated Hospital of Nanjing Medical University

liqg@njmu.edu.cn1391389923

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026